Cargando…

Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021

BACKGROUND: Seroprevalence studies have been carried out in many developed and developing countries to evaluate ongoing and past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Data on this infection in marginalized populations in urban slums are limited, which may offer...

Descripción completa

Detalles Bibliográficos
Autores principales: Raqib, Rubhana, Sarker, Protim, Akhtar, Evana, Nurul Huda, Tarique Mohammad, Haq, Md. Ahsanul, Roy, Anjan Kumar, Hosen, Md. Biplob, Haque, Farjana, Chowdhury, Md. Razib, Reidpath, Daniel D., Emdadul Hoque, Dewan Md., Islam, Zahirul, Ahmed, Shehlina, Ahmed, Tahmeed, Tofail, Fahmida, Razzaque, Abdur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126397/
https://www.ncbi.nlm.nih.gov/pubmed/35604947
http://dx.doi.org/10.1371/journal.pone.0268093
_version_ 1784712120159436800
author Raqib, Rubhana
Sarker, Protim
Akhtar, Evana
Nurul Huda, Tarique Mohammad
Haq, Md. Ahsanul
Roy, Anjan Kumar
Hosen, Md. Biplob
Haque, Farjana
Chowdhury, Md. Razib
Reidpath, Daniel D.
Emdadul Hoque, Dewan Md.
Islam, Zahirul
Ahmed, Shehlina
Ahmed, Tahmeed
Tofail, Fahmida
Razzaque, Abdur
author_facet Raqib, Rubhana
Sarker, Protim
Akhtar, Evana
Nurul Huda, Tarique Mohammad
Haq, Md. Ahsanul
Roy, Anjan Kumar
Hosen, Md. Biplob
Haque, Farjana
Chowdhury, Md. Razib
Reidpath, Daniel D.
Emdadul Hoque, Dewan Md.
Islam, Zahirul
Ahmed, Shehlina
Ahmed, Tahmeed
Tofail, Fahmida
Razzaque, Abdur
author_sort Raqib, Rubhana
collection PubMed
description BACKGROUND: Seroprevalence studies have been carried out in many developed and developing countries to evaluate ongoing and past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Data on this infection in marginalized populations in urban slums are limited, which may offer crucial information to update prevention and mitigation policies and strategies. We aimed to determine the seroprevalence of SARS-CoV-2 infection and factors associated with seropositivity in slum and non-slum communities in two large cities in Bangladesh. METHODS: A cross-sectional study was carried out among the target population in Dhaka and Chattogram cities between October 2020 and February 2021. Questionnaire-based data, anthropometric and blood pressure measurements and blood were obtained. SARS-CoV-2 serology was assessed by Roche Elecsys® Anti-SARS-CoV-2 immunoassay. RESULTS: Among the 3220 participants (2444 adults, ≥18 years; 776 children, 10–17 years), the overall weighted seroprevalence was 67.3% (95% confidence intervals (CI) = 65.2, 69.3) with 71.0% in slum (95% CI = 68.7, 72.2) and 62.2% in non-slum (95% CI = 58.5, 65.8). The weighted seroprevalence was 72.9% in Dhaka and 54.2% in Chattogram. Seroprevalence was positively associated with limited years of formal education (adjusted odds ratio [aOR] = 1.61; 95% CI = 1.43, 1.82), lower income (aOR = 1.23; 95% CI = 1.03, 1.46), overweight (aOR = 1.2835; 95% CI = 1.26, 1.97), diabetes (aOR = 1.67; 95% CI = 1.21, 2.32) and heart disease (aOR = 1.38; 95% CI = 1.03, 1.86). Contrarily, negative associations were found between seropositivity and regular wearing of masks and washing hands, and prior BCG vaccination. About 63% of the population had asymptomatic infection; only 33% slum and 49% non-slum population showed symptomatic infection. CONCLUSION: The estimated seroprevalence of SARS-CoV-2 was more prominent in impoverished informal settlements than in the adjacent middle-income non-slum areas. Additional factors associated with seropositivity included limited education, low income, overweight and pre-existing chronic conditions. Behavioral factors such as regular wearing of masks and washing hands were associated with lower probability of seropositivity.
format Online
Article
Text
id pubmed-9126397
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-91263972022-05-24 Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021 Raqib, Rubhana Sarker, Protim Akhtar, Evana Nurul Huda, Tarique Mohammad Haq, Md. Ahsanul Roy, Anjan Kumar Hosen, Md. Biplob Haque, Farjana Chowdhury, Md. Razib Reidpath, Daniel D. Emdadul Hoque, Dewan Md. Islam, Zahirul Ahmed, Shehlina Ahmed, Tahmeed Tofail, Fahmida Razzaque, Abdur PLoS One Research Article BACKGROUND: Seroprevalence studies have been carried out in many developed and developing countries to evaluate ongoing and past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Data on this infection in marginalized populations in urban slums are limited, which may offer crucial information to update prevention and mitigation policies and strategies. We aimed to determine the seroprevalence of SARS-CoV-2 infection and factors associated with seropositivity in slum and non-slum communities in two large cities in Bangladesh. METHODS: A cross-sectional study was carried out among the target population in Dhaka and Chattogram cities between October 2020 and February 2021. Questionnaire-based data, anthropometric and blood pressure measurements and blood were obtained. SARS-CoV-2 serology was assessed by Roche Elecsys® Anti-SARS-CoV-2 immunoassay. RESULTS: Among the 3220 participants (2444 adults, ≥18 years; 776 children, 10–17 years), the overall weighted seroprevalence was 67.3% (95% confidence intervals (CI) = 65.2, 69.3) with 71.0% in slum (95% CI = 68.7, 72.2) and 62.2% in non-slum (95% CI = 58.5, 65.8). The weighted seroprevalence was 72.9% in Dhaka and 54.2% in Chattogram. Seroprevalence was positively associated with limited years of formal education (adjusted odds ratio [aOR] = 1.61; 95% CI = 1.43, 1.82), lower income (aOR = 1.23; 95% CI = 1.03, 1.46), overweight (aOR = 1.2835; 95% CI = 1.26, 1.97), diabetes (aOR = 1.67; 95% CI = 1.21, 2.32) and heart disease (aOR = 1.38; 95% CI = 1.03, 1.86). Contrarily, negative associations were found between seropositivity and regular wearing of masks and washing hands, and prior BCG vaccination. About 63% of the population had asymptomatic infection; only 33% slum and 49% non-slum population showed symptomatic infection. CONCLUSION: The estimated seroprevalence of SARS-CoV-2 was more prominent in impoverished informal settlements than in the adjacent middle-income non-slum areas. Additional factors associated with seropositivity included limited education, low income, overweight and pre-existing chronic conditions. Behavioral factors such as regular wearing of masks and washing hands were associated with lower probability of seropositivity. Public Library of Science 2022-05-23 /pmc/articles/PMC9126397/ /pubmed/35604947 http://dx.doi.org/10.1371/journal.pone.0268093 Text en © 2022 Raqib et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Raqib, Rubhana
Sarker, Protim
Akhtar, Evana
Nurul Huda, Tarique Mohammad
Haq, Md. Ahsanul
Roy, Anjan Kumar
Hosen, Md. Biplob
Haque, Farjana
Chowdhury, Md. Razib
Reidpath, Daniel D.
Emdadul Hoque, Dewan Md.
Islam, Zahirul
Ahmed, Shehlina
Ahmed, Tahmeed
Tofail, Fahmida
Razzaque, Abdur
Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021
title Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021
title_full Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021
title_fullStr Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021
title_full_unstemmed Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021
title_short Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021
title_sort seroprevalence of sars-cov-2 infection and associated factors among bangladeshi slum and non-slum dwellers in pre-covid-19 vaccination era: october 2020 to february 2021
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126397/
https://www.ncbi.nlm.nih.gov/pubmed/35604947
http://dx.doi.org/10.1371/journal.pone.0268093
work_keys_str_mv AT raqibrubhana seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT sarkerprotim seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT akhtarevana seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT nurulhudatariquemohammad seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT haqmdahsanul seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT royanjankumar seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT hosenmdbiplob seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT haquefarjana seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT chowdhurymdrazib seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT reidpathdanield seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT emdadulhoquedewanmd seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT islamzahirul seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT ahmedshehlina seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT ahmedtahmeed seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT tofailfahmida seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021
AT razzaqueabdur seroprevalenceofsarscov2infectionandassociatedfactorsamongbangladeshislumandnonslumdwellersinprecovid19vaccinationeraoctober2020tofebruary2021